This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 May 31;361(9372):1915.

doi: 10.1016/S0140-6736(03)13531-3.

Hormonal contraception and cervical cancer

Richard J Epstein

PMID: 12788614
DOI: 10.1016/S0140-6736(03)13531-3

Comment

Hormonal contraception and cervical cancer

Richard J Epstein. Lancet. 2003.

. 2003 May 31;361(9372):1915.

doi: 10.1016/S0140-6736(03)13531-3.

Author

Richard J Epstein

PMID: 12788614
DOI: 10.1016/S0140-6736(03)13531-3

No abstract available

PubMed Disclaimer

Comment on

Cervical cancer and use of hormonal contraceptives: a systematic review.
Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V. Smith JS, et al. Lancet. 2003 Apr 5;361(9364):1159-67. doi: 10.1016/s0140-6736(03)12949-2. Lancet. 2003. PMID: 12686037

Similar articles

Oral contraceptives, parity, and cervical cancer.
Skegg DC. Skegg DC. Lancet. 2002 Mar 30;359(9312):1080-1. doi: 10.1016/S0140-6736(02)08125-4. Lancet. 2002. PMID: 11943251 No abstract available.
Oral contraceptives and cervical cancer.
Brabin L, Barr F. Brabin L, et al. Lancet. 2002 Aug 3;360(9330):409-10. doi: 10.1016/S0140-6736(02)09577-6. Lancet. 2002. PMID: 12241799 No abstract available.
Cervical cancer prevention and hormonal contraception.
Sasieni P. Sasieni P. Lancet. 2007 Nov 10;370(9599):1591-2. doi: 10.1016/S0140-6736(07)61667-5. Lancet. 2007. PMID: 17993345 No abstract available.
[Risk factors and prevention of uterine cervical cancer].
Kawagoe T, Toki N, Matsuura Y, Kashimura M. Kawagoe T, et al. Nihon Rinsho. 2004 Oct;62 Suppl 10:233-6. Nihon Rinsho. 2004. PMID: 15535242 Review. Japanese. No abstract available.
[Hormonal contraception as a risk factor for developing cervical cancer: biological, epidemiological and immunological evidence].
Castro Romero JI, Hernández Girón C, Madrid Marina V. Castro Romero JI, et al. Ginecol Obstet Mex. 2011 Sep;79(9):533-9. Ginecol Obstet Mex. 2011. PMID: 21966853 Review. Spanish.

See all similar articles

Cited by

Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
McFarlane-Anderson N, Bazuaye PE, Jackson MD, Smikle M, Fletcher HM. McFarlane-Anderson N, et al. BMC Womens Health. 2008 May 30;8:9. doi: 10.1186/1472-6874-8-9. BMC Womens Health. 2008. PMID: 18513406 Free PMC article.
Influence of oral contraceptives on lipid profile and paraoxonase and commonly hepatic enzymes activities.
Kowalska K, Ściskalska M, Bizoń A, Śliwińska-Mossoń M, Milnerowicz H. Kowalska K, et al. J Clin Lab Anal. 2018 Jan;32(1):e22194. doi: 10.1002/jcla.22194. Epub 2017 Mar 9. J Clin Lab Anal. 2018. PMID: 28276605 Free PMC article.
Is there any association between hormonal contraceptives and cervical neoplasia in a poor Nigerian setting?
Ajah LO, Chigbu CO, Ozumba BC, Oguanuo TC, Ezeonu PO. Ajah LO, et al. Onco Targets Ther. 2015 Jul 27;8:1887-92. doi: 10.2147/OTT.S86472. eCollection 2015. Onco Targets Ther. 2015. PMID: 26251619 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information